German CDMO Corden Pharma is investing €900m to expand its diabetes drug manufacturing capabilities, focusing on GLP-1 peptide manufacturing due to rising demand.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
German CDMO Corden Pharma is investing €900m to expand its diabetes drug manufacturing capabilities, focusing on GLP-1 peptide manufacturing due to rising demand.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.